Epstein–Barr Virus Detection in Lymphoproliferative Disorders: Epidemiological Characterization in Western Mexico

View Full Paper

Ask AI

Bookmark

EBV detection frequency reached 35.5%, with significant variation between neoplastic and reactive lymphoproliferative disorders.
Hodgkin lymphoma exhibited the highest EBV detection rate at 80.6%, significantly more than non-Hodgkin lymphoma's 39.3%.
Cross-sectional analysis involved 200 tissue samples using real-time PCR and immunohistochemistry for accurate detection.
Epidemiological findings establish a baseline for regional characteristics and future longitudinal research efforts.

Discussion

No takes yet. Share an insight, caveat, or question.

Cross-sectional assessment found 35.5% EBV detection in lymphoproliferative disorders, suggesting varying prevalence by type and age.

Licona-Lasteros et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark